takeda to buy swiss drugmaker nycomed for $13.6 billion
takeda pharmaceutical co , japan's largest drugmaker, is buying privately held swiss rival nycomed for $13.6 billion, giving it access to a newly approved lung-disease drug, which is expected to be a major source of revenue growth.
http://feeds.reuters.com/~r/reuters/businessnews/~3/e6nlcvnwlg4/us-takeda-nycomed-idustre74i15620110519
29081
19 May 2011 12:05:14
reuters
business